Cost-effectiveness of treating multidrug-resistant tuberculosis in treatment initiative centers and treatment follow-up centers in Ethiopia.

Senait AlemayehuAmanuel YigezuDamen HailemariamAlemayehu Hailu

Published in: PloS one (2020)

This study indicates that the treatment of MDR-TB at both TIC and TFC are cost-effective interventions compared with the willingness to pay threshold of three-times the GDP per capita in Ethiopia.

Keyphrases

multidrug resistant
mycobacterium tuberculosis
combination therapy
quality improvement
acinetobacter baumannii
pulmonary tuberculosis
klebsiella pneumoniae